40032-80-2

Basic information

• Product Name: 3-Bromo-4-(bromomethyl)thiophene 95%
• Synonyms: 3-Bromo-4-(bromomethyl)thiophene 95%;3-BROMO-4-(BROMOMETHYL)THIOPHENE;3-Bromo-4-(bromomethyl)thiophene95%
• CAS NO: 40032-80-2
• Molecular Formula: C5H4Br2S
• Molecular Weight: 255.97
• Mol File: 40032-80-2.mol

Chemical Properties

• Boiling Point: 257.4°C at 760 mmHg
• Flash Point: 109.5°C
• Appearance: /
• Density: 2.054g/cm³
• Vapor Pressure: 0.0235mmHg at 25°C
• Refractive Index: 1.641
• CAS DataBase Reference: 3-Bromo-4-(bromomethyl)thiophene 95%(CAS DataBase Reference)
• NIST Chemistry Reference: 3-Bromo-4-(bromomethyl)thiophene 95%(40032-80-2)
• EPA Substance Registry System: 3-Bromo-4-(bromomethyl)thiophene 95%(40032-80-2)

Safety Data

• Hazard Codes: C
• Hazardous Substances Data: 40032-80-2(Hazardous Substances Data)

Usage

InChI:InChI=1/C5H4Br2S/c6-1-4-2-8-3-5(4)7/h2-3H,1H2

Upstream product

• 30318-99-1 3-bromo-4-methylthiophene 
• 34241-39-9 azobisisobutyronitrile 

Relevant articles and documents

Synthesis, Structure, and Dynamics of Chiral Eight-Membered Cyclic Molecules with Thienylene and Cyclopropylene Units Alternately Connected

A rhodium(II)-catalyzed asymmetric cyclooligomerization of bifunctional monomers possessing triazolyl and vinyl groups at 2,3- and 3,4-positions on the thiophene ring is studied. Structurally interesting cyclic dimers in which thienylene and cyclopropylene units are alternately connected are obtained as the major components. The eight-membered rings in the center are non-planar and adopt a tub-shaped conformation. We also observe the phenomenon of racemization caused by a tub-to-tub ring-flipping, the activation energy of which is determined as 108 kJ mol?1 by electronic circular dichroism spectra measurement.

IMIDAZOPIPERAZINE INHIBITORS OF TRANSCRIPTION ACTIVATING PROTEINS

The present disclosure relates to heterocyclic compounds and methods which may be useful as inhibitors of transcription activating proteins such as CBP and P300 for the treatment or prevention of diseases such as proliferative diseases, inflammatory disorders, autoimmune diseases, and fibrotic diseases.

Discovery of N-Substituted (2-Phenylcyclopropyl)methylamines as Functionally Selective Serotonin 2C Receptor Agonists for Potential Use as Antipsychotic Medications

A series of N-substituted (2-phenylcyclopropyl)methylamines were designed and synthesized, with the aim of finding serotonin 2C (5-HT2C)-selective agonists with a preference for Gq signaling. A number of these compounds exhibit 5-HT2C selectivity with a preference for Gq-mediated signaling compared with β-arrestin recruitment. Furthermore, the N-methyl compound (+)-15a, which displayed an EC50 of 23 nM in the calcium flux assay while showing no β-arrestin recruitment activity, is the most functionally selective 5-HT2C agonist reported to date. The N-benzyl compound (+)-19, which showed an EC50 of 24 nM at the 5-HT2C receptor, is fully selective over the 5-HT2B receptor. In an amphetamine-induced hyperactivity model, compound (+)-19 showed significant antipsychotic-drug-like activity. These novel compounds shed light on the role of functional selectivity at the 5-HT2C receptor with respect to antipsychotic activity.

Design and synthesis of thiophene dihydroisoquinolines as novel BACE1 inhibitors

Utilizing a structure based design approach, combined with extensive medicinal chemistry execution, highly selective, potent and novel BACE1 inhibitor 8 (BACE1 Alpha assay IC50 = 8 nM) was made from a weak μM potency hit in an extremely efficient way. The detailed SAR and general design approaches will be discussed.

Diastereo- and enantioselective intramolecular C(sp3)-H arylation for the synthesis of fused cyclopentanes

All C-H bonds are not equal: The intramolecular arylation of unactivated C(sp3)-H bonds in the presence of a chiral Pd/binepine catalyst allows the synthesis of fused cyclopentanes efficiently and in an diastereo- and enantioselective manner (see scheme).

Phosphorylamides, their preparation and use

A phosphorylamide derivative represented by the general formula (I): STR1 wherein R represents an amino group that may be substituted, or a salt thereof, possesses potent antibacterial activity against Helicobacter bacterium, especially Helicobacter pylori, and is useful for prevention or treatment of digestive diseases caused by Helicobacter bacterium, solely or in combination with an antacid or an acid secretion inhibitor.